Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,155 total articles

Stocks Swing Widely on Tuesday; Rambus Plunges as Centene, Sanmina and Several Small Caps Rally

Stocks Swing Widely on Tuesday; Rambus Plunges as Centene, Sanmina and Several Small Caps Rally

Tuesday's trading session featured pronounced shifts across market-cap segments. Large-cap technology and semiconductor names led declines among mega-caps, while healthcare and selected small- and mid-cap companies posted double-digit gains after earnings beats, analyst ratings and early-stage trial news. Rambus fell sharply on an analyst downgrade…

Google Withdraws From $100 Million Pentagon Drone-Swarm Competition

Google Withdraws From $100 Million Pentagon Drone-Swarm Competition

Google informed the U.S. government on Feb. 11 that it would not continue in a $100 million Pentagon effort to develop voice-controlled autonomous drone swarm technology. The withdrawal followed the company’s proposal being accepted and, according to records, came after an internal ethics review. Alphabet’s Google officially attributed the exit to …

OpenAI Rebuts Report Questioning User and Revenue Targets

OpenAI Rebuts Report Questioning User and Revenue Targets

OpenAI pushed back against a report that it missed internal targets for new users and revenue and that leadership was worried about financing future data-center contracts. The company cited product and enterprise strength on social media and told Bloomberg that its business is "firing on all cylinders," with enterprise and advertising businesses ex…

FDA Opens Pilot to Test Artificial Intelligence in Early Drug Development

FDA Opens Pilot to Test Artificial Intelligence in Early Drug Development

The U.S. Food and Drug Administration has launched a pilot program to evaluate the use of artificial intelligence and data science in regulatory decision-making for drug and biologic development, focusing on preclinical and early clinical stages. The agency will publish the notice in the Federal Register on April 29 and is accepting applications th…